Seeking AlphaWed, 22 Apr 2026 19:31:10 GMTKyverna Therapeutics: 'Strong Buy' On Additional POC Of Miv-Cel In Myasthenia GravisKYTX+5.38%
Seeking AlphaTue, 21 Apr 2026 11:30:22 GMTKyverna Therapeutics Positive Phase 2 Readout: Deep Responses, But Very Small SampleKYTX+5.38%
Seeking AlphaTue, 03 Mar 2026 06:02:14 GMTKyverna Therapeutics: The King Of The CAR-T Autoimmune RevolutionKYTX+5.38%